Febit has launched a human cancer biochip for sequence capture with its HybSelect technology. The catalog chip includes 115 genes known to be associated with common types of cancer. The company also plans to launch a 2-megabase exon cancer biochip this summer and a 30-megabase biochip next year.
New Products: Jul 21, 2009
Jul 21, 2009